LTUS Lotus Pharmaceuticals Inc.

NSD
$0.00

Lotus Pharmaceuticals Inc. (LTUS) is expected to report earnings on November 11, 2026, after the market close.

Lotus Pharmaceuticals Reported Earnings
Wednesday, August 12, 2026 · 12:00 AM ET
Earnings Date
Nov 11
Wednesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lotus Pharmaceuticals Inc.

Lotus Pharmaceuticals, Inc. operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd., collectively Lotus East. The Company believes Lotus East has some of the most advanced pharmaceutical production equipment in China and its manufacturing facilities meet national Good Manufacturing Practices. The Company distributes its own portfolio of drugs and pharmaceutical products produced by other manufacturers in the People's Republic of China through an extensive national distribution network. Liang Fang owns and operates drug stores throughout Beijing, China that sell Western and traditional Chinese medications and lease medical treatment facilities to licensed physicians. En Zhe Jia is a manufacturer for Liang Fang and maintains facilities for the production of medicines, Chinese medicine, as well as the research and production of other new medicines.

Industry

Restaurants

Charts powered in part by Lightweight Charts™ by TradingView.